MORGAN STANLEY - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 21 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q3 2023$674
-31.7%
1210.0%0.00%
Q2 2023$987
-17.8%
121
-29.2%
0.00%
Q1 2023$1,200
-16.0%
1710.0%0.00%
Q4 2022$1,428
+42.8%
171
-1.2%
0.00%
Q3 2022$1,000173
+246.0%
0.00%
Q2 2022$0
-100.0%
50
-80.0%
0.00%
Q1 2022$3,000
-75.0%
250
-65.3%
0.00%
Q4 2021$12,000
+1100.0%
721
+1342.0%
0.00%
Q3 2021$1,000
-66.7%
50
-66.7%
0.00%
Q2 2021$3,0001500.00%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q3 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 577,909$4,686,8429.21%
VILLERE ST DENIS J & CO LLC 292,723$2,388,6190.17%
PINNACLE ASSOCIATES LTD 484,653$3,954,7680.07%
FNY Investment Advisers, LLC 1,539$120.02%
BENJAMIN F. EDWARDS & COMPANY, INC. 49,210$3990.02%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,171$187,9170.00%
BROWN ADVISORY INC 73,849$602,6080.00%
Geneos Wealth Management Inc. 750$6,0830.00%
Focused Wealth Management, Inc 242$1,9750.00%
UBS Group AG 6,548$53,4320.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders